Annual Accounts Payable
$3.21 M
-$2.07 M-39.21%
December 31, 2022
Summary
- As of February 8, 2025, AMAM annual accounts payable is $3.21 million, with the most recent change of -$2.07 million (-39.21%) on December 31, 2022.
- During the last 3 years, AMAM annual accounts payable has fallen by -$2.19 million (-40.54%).
Performance
AMAM Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$5.14 M
-$1.22 M-19.19%
September 1, 2023
Summary
- As of February 8, 2025, AMAM quarterly accounts payable is $5.14 million, with the most recent change of -$1.22 million (-19.19%) on September 1, 2023.
Performance
AMAM Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AMAM Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.2% | - |
| 3 y3 years | -40.5% | +82.3% |
| 5 y5 years | -40.5% | - |
AMAM Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.2% | at low | -27.7% | -37.7% |
| 5 y | 5-year | -40.5% | -12.0% | -27.7% | -45.1% |
| alltime | all time | -40.5% | -12.0% | -27.7% | -45.1% |
Ambrx Biopharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $5.14 M(-19.2%) |
| Jun 2023 | - | $6.36 M(-10.5%) |
| Mar 2023 | - | $7.11 M(+121.7%) |
| Dec 2022 | $3.21 M(-39.2%) | $3.21 M(-43.7%) |
| Jun 2022 | - | $5.70 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $5.27 M(+87.0%) | - |
| Dec 2021 | - | $5.27 M(+39.9%) |
| Jun 2021 | - | $3.77 M(+33.6%) |
| Dec 2020 | $2.82 M(-47.7%) | - |
| Dec 2020 | - | $2.82 M |
| Dec 2019 | $5.39 M | - |
FAQ
- What is Ambrx Biopharma annual accounts payable?
- What is the all time high annual accounts payable for Ambrx Biopharma?
- What is Ambrx Biopharma annual accounts payable year-on-year change?
- What is Ambrx Biopharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Ambrx Biopharma?
What is Ambrx Biopharma annual accounts payable?
The current annual accounts payable of AMAM is $3.21 M
What is the all time high annual accounts payable for Ambrx Biopharma?
Ambrx Biopharma all-time high annual accounts payable is $5.39 M
What is Ambrx Biopharma annual accounts payable year-on-year change?
Over the past year, AMAM annual accounts payable has changed by -$2.07 M (-39.21%)
What is Ambrx Biopharma quarterly accounts payable?
The current quarterly accounts payable of AMAM is $5.14 M
What is the all time high quarterly accounts payable for Ambrx Biopharma?
Ambrx Biopharma all-time high quarterly accounts payable is $7.11 M